Search results
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...
New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering.
Barrons.com· 1 day agoDrugmakers are aiming to launch this year’s shots by the beginning of September but have been...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 1 day agovaccine to enter the US market following the launches of GSK’s Arexvy and Pfizer’s Abrysvo in 2023....
2 Dividend Stocks Billionaires Are Buying: Should You? | The Motley Fool
The Motley Fool· 8 hours agoMany billionaires are active on Wall Street and largely built their wealth that way. Of course,...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
Reuters· 7 days agoModerna's vaccine was approved for the prevention of RSV-associated lower respiratory tract disease...
F.D.A. Advisers Recommend a New Covid Vaccine Formula for the Fall
New York Times· 2 days agoA committee of advisers to the Food and Drug Administration voted on Wednesday to update the formula...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 4 hours agoJN.1 and its descendants KP.2 and KP.3 are the versions of the virus that are most common in the...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 3 days agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 3 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...